MDXH
Closed
Mdxhealth Sa Adr
2.12
-0.09 (-4.07%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 2.21
Day's Range: 2.12 - 2.22
Send
sign up or login to leave a comment!
When Written:
3.18
MDxHealth SA is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and personalized treatment. The company is headquartered in Belgium and has operations in the United States and Europe. MDxHealth's tests are designed to aid in the diagnosis and management of cancer by providing information on the molecular and genetic characteristics of tumors. The company's flagship product is the ConfirmMDx for Prostate Cancer test, which helps to identify men who may have been misdiagnosed with low-grade prostate cancer and who may not require immediate treatment. MDxHealth is listed on the Euronext Brussels stock exchange and has American Depositary Receipts (ADRs) listed on the OTCQX market in the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








